에틸 (S)-1-페닐-1,2,3,4-테트라히드로-2-이소퀴놀린카르복실레이트

기본 정보

• 표준명: 에틸 (S)-1-페닐-1,2,3,4-테트라히드로-2-이소퀴놀린카르복실레이트
• CAS 레지스트리 번호: 180468-42-2
• 분자식: C
• 분자 무게: 281.354
• Mol 파일: 180468-42-2.mol

동의어: ETHYL (S)-1-PHENYL-1,2,3,4-TETRAHYDRO-2-ISOQUINOLINECARBOXYLATE;(S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid ethyl ester;(S)-ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate;4-tetrahydro-2-isoquinolinecarboxylate;Ethyl (S)-1-phenyl-1;(1S)-Ethyl-1-phenyl-1,2,3,4-tetrahydro-2-isoquinoline carboxylate;2(1H)-Isoquinolinecarboxylic acid,3,4-dihydro-1-phenyl-,ethyl ester,(1S)-;propyl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

관련 CAS 번호: 1000017-93-5 1000017-94-6 1000017-95-7 1000017-98-0 1000018-03-0 1000018-06-3 1000018-13-2 1000018-17-6 1000018-21-2 1000018-25-6

표준명의 화학적 성질

물리적 데이터:

안전정보:

• 픽토그램:
• 위험 코드:
• 진술:
• 안전 선언문:

사용:

• 소개 및 적용: Solifenacin is a medication used to treat overactive bladder (OAB) with symptoms of urinary urgency, frequency, and incontinence. It works by blocking the muscles of the bladder, allowing for better control over urination. The recommended dose of Solifenacin is 5-10 mg once daily, with or without food. It is important to follow the instructions provided by a healthcare professional and not to exceed the prescribed dose. Common side effects of Solifenacin may include dry mouth, constipation, and difficulty emptying the bladder. It is also important to note that Solifenacin may interact with other medications, so it is crucial to inform a healthcare provider of any other medications being taken.